Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

EndoPod

Dexamethasone

28 Jun 2020

Description

This week on EndoPod we’ll be exploring the promising drug, dexamethasone and how it’s proved to be effective in the current coronavirus pandemic. Sit back and enjoy! Disclaimer: Aberdeen University Endocrinology Society are a student lead organisation. All information provided in this podcast are intended for educational purposes. This podcast is not intended to replace the advice of a qualified health professional. The students involved in the making of this episode are in the 3rd year of MBChB studies (Hepsi Xavier, John Saganty) References: http://www.ox.ac.uk/news/2020-06-16-dexamethasone-reduces-death-hospitalised-patients-severe-respiratory-complications# https://www.recoverytrial.net/study-faq https://www.telegraph.co.uk/news/0/what-dexamethasone-coronavirus-treatment/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662771/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047790/ https://www.aljazeera.com/indepth/features/doctor-note-dexamethasone-treat-covid-19-200515154943918.html?fbclid=IwAR3BwXX1zpu3QIhpiRGJIQzJ7QxPUJHkr2Nuxaz3NgBlb5fwzhroWS0LSws https://www.medscape.com/viewarticle/932659?fbclid=IwAR20gu0doZE-DU1I2YAdE3oK-j1EE_uhP0ey-ztuK1eISQ1aC2C6veq54ZE https://www.newscientist.com/article/dn10201-body-reveals-its-inflammation-off-switch/ https://www.health.com/condition/infectious-diseases/coronavirus/what-is-ards https://www.sciencedirect.com/science/article/pii/S1359610120300927 https://www.bbc.co.uk/news/health-53077879 https://www.medrxiv.org/content/10.1101/2020.04.23.20076042v1.full.pdf?fbclid=IwAR2U6BpqnoVKv2FSVoAGUQu9i0GHBo-ZrWrt_pq_jwTq4ihHRFk9hoLbJ18

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.